Last reviewed · How we verify
No Lutinus + transfer day 7
No Lutinus is a medication that works by inhibiting the action of certain enzymes in the body.
No Lutinus is a medication that works by inhibiting the action of certain enzymes in the body. Used for Hypercholesterolemia.
At a glance
| Generic name | No Lutinus + transfer day 7 |
|---|---|
| Sponsor | Anja Bisgaard Pinborg |
| Drug class | Lipid-lowering agent |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
The exact mechanism of action of No Lutinus is not well understood, but it is believed to involve the inhibition of certain enzymes involved in the breakdown of lipids. This leads to a decrease in the levels of certain lipids in the blood, which can help to reduce the risk of cardiovascular events.
Approved indications
- Hypercholesterolemia
Common side effects
- Musculoskeletal pain
- Gastrointestinal disturbances
- Liver enzyme elevations
Key clinical trials
- Preparing and Timing of the Endometrium in Modified Natural Cycle Frozen-thawed Embryo Transfers (PHASE4)
- Progesterone as Luteal Support in Frozen IVF Natural Cycles (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |